FLUOROURACIL ALPHAPHARM fluorouracil 2.5 g/50 mL solution for injection vial

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

fluorouracil, Quantity: 2.5 g

Disponible depuis:

MedTAS Pty Ltd

forme pharmaceutique:

Injection, solution

Composition:

Excipient Ingredients: water for injections; sodium hydroxide

Mode d'administration:

Intravenous

Unités en paquet:

10 vials, 1 vial, 5 vials

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,Fluorouracil should only be used when other proven measures have failed or are considered,impractical.

Descriptif du produit:

Visual Identification: A clear, colorless to yellow aqueous solution, free from visible particles.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Registered

Date de l'autorisation:

2022-01-14